Navigation Links
Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery
Date:12/27/2011

ast, 2010-2017 53

Figure 30: Diabetes Care Devices, Italy, Category Volume (Units), 2003-2017 55

Figure 31: Diabetes Care Devices, Italy, Category Volume (Units), Historic, 2003-2010 56

Figure 32: Diabetes Care Devices, Italy, Category Volume (Units), Forecast, 2010-2017 57

Figure 33: Diabetes Care Devices, Italy, Company share (%), 2010 59

Figure 34: Glucose Monitoring, Italy, Company share (%), 2010 61

Figure 35: Insulin Delivery, Italy, Company share (%), 2010 62

Figure 36: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Actual, 2003-2017 64

Figure 37: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Actual, Historic, 2003-2010 65

Figure 38: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 66

Figure 39: Diabetes Care Devices, Spain, Category Volume (Units), 2003-2017 67

Figure 40: Diabetes Care Devices, Spain, Category Volume (Units), Historic, 2003-2010 68

Figure 41: Diabetes Care Devices, Spain, Category Volume (Units), Forecast, 2010-2017 69

Figure 42: Diabetes Care Devices, Spain, Company share (%), 2010 71

Figure 43: Glucose Monitoring, Spain, Company share (%), 2010 73

Figure 44: Insulin Delivery, Spain, Company share (%), 2010 74

Figure 45: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Actual, 2003-2017 76

Figure 46: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Actual, Historic, 2003-2010 78

Figure 47: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 80

Figure 48: Diabetes Care Devices, United Kingdom, Category Volume (Units), 2003-2017 82

Figure 49: Diabetes Care Devices, United Kingdom, Category Volume (Units), Historic, 2003-2010 83

Figure 50: Diabetes Care Devices, United Kingdom, Category Volume (Units), Forecast, 2010-2017 84

Figure 51: Diabetes Care Devices, United Ki
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
2. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
3. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
4. European Experts Recommend Pregnant and Nursing Women Take More DHA - Every Day
5. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
6. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
7. Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO)
8. BioMosaics Glypican-3 Blood & Tissue Tests Receive CE Marking in Europe
9. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
10. Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System
11. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Calif. , Nov. 26, 2014  Thoratec Corporation ... device-based mechanical circulatory support therapies to save, support and ... in two upcoming investor conferences. On Tuesday, ... th Annual Piper Jaffray Healthcare Conference.  D. ... provide an update on the company beginning at 11:30 ...
(Date:11/26/2014)... , Nov. 26, 2014  Genomic Health, Inc. ... Popovits , Chairman, Chief Executive Officer and President, will ... Healthcare Conference at The New York Palace Hotel in ... 3 at 11:30 am Eastern Time (ET). ... the conference call, go to the  Investor Relations  section ...
(Date:11/26/2014)... , November 26, 2014 Investor-Edge ... VVUS ), Horizon Pharma PLC (NASDAQ: ... and Johnson (NYSE: JNJ ), and Theravance Inc. ... companies can be accessed at: http://investor-edge.com/register . ... 4,758.25, up 0.07%, the Dow Jones Industrial Average edged 0.02% ...
Breaking Medicine Technology:Thoratec Announces Presentations At Investor Conferences For December 2014 2Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 2Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5
... findings of the first cost-effectiveness analysis of Vimpat® ... partial-onset seizures.  The findings were presented at the ... (ISPOR) annual meeting in Baltimore, MD, USA.   ... to analyze standard anti-epileptic drug therapy with and ...
... Pa., May 31, 2011 CSL Behring ... Designations (ODD) by the European Commission for the development of ... (rVIIa-FP), a novel therapy to treat hemophilia A and hemophilia ... to exclusively market recombinant factor VIIa fused with albumin in ...
Cached Medicine Technology:New Analysis Shows Potential Cost Savings of Adding Antiepileptic Drug Vimpat® C-V 2New Analysis Shows Potential Cost Savings of Adding Antiepileptic Drug Vimpat® C-V 3New Analysis Shows Potential Cost Savings of Adding Antiepileptic Drug Vimpat® C-V 4New Analysis Shows Potential Cost Savings of Adding Antiepileptic Drug Vimpat® C-V 5New Analysis Shows Potential Cost Savings of Adding Antiepileptic Drug Vimpat® C-V 6New Analysis Shows Potential Cost Savings of Adding Antiepileptic Drug Vimpat® C-V 7New Analysis Shows Potential Cost Savings of Adding Antiepileptic Drug Vimpat® C-V 8CSL Behring Receives EU Orphan Drug Designations for rVIIa-FP for Hemophilia A and B Treatment 2CSL Behring Receives EU Orphan Drug Designations for rVIIa-FP for Hemophilia A and B Treatment 3CSL Behring Receives EU Orphan Drug Designations for rVIIa-FP for Hemophilia A and B Treatment 4
(Date:11/27/2014)... (PRWEB) November 27, 2014 In order to ... from Sharpes, Fla., designed an easy way to avoid touching ... , He then created a prototype of the patent-pending Toilet ... lower a toilet seat and/or lid in a more sanitary ... the spread of germs. Overall, it promotes good hygiene and ...
(Date:11/27/2014)... November 27, 2014 The founders of VIM ... comfortable and high functioning compression socks, are proud to announce ... use an innovative Gradient Pressure (TM) knitting technology that is ... VIM & VIGR’s commitment to adding flair and style to ... functional recently caught the eye of a writer at ...
(Date:11/27/2014)... Jeffrey Carlini has practiced public ... area providing audits, reviews, compilations, tax preparation, business ... varying size across numerous industries. Jeff has worked ... of their accounting and tax needs. , Jeff ... Program. When asking Mr. Carlini about his recent ...
(Date:11/27/2014)... Vegas, NV (PRWEB) November 27, 2014 ... 2014 shopping season has officially launched, Emassagechair.com ... and Cyber Monday Discount Event. , Negotiating on ... relationships with top massage chair brands, Emassagechair.com has generated ... their best deals and biggest discounts yet. , Shoppers ...
(Date:11/27/2014)... York, New York (PRWEB) November 27, 2014 ... of individuals who were allegedly injured by the medication ... where a federal litigation is looking ahead to a ... , According to a Scheduling Order issued earlier this ... place on December 16th at 10:00 a.m. Items likely ...
Breaking Medicine News(10 mins):Health News:VIM & VIGR Announces Launch of Men’s Line of Compression Socks 2Health News:Jeffrey Carlini becomes Intuit Proadvisor and receives QuickBooks certification 2Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 2Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 3Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 4Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 2Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 3
... New Dynamics of Ageing Programme (NDA), a collaboration between ... and Humanities Research Council, the Biotechnology and Biological Sciences ... the Economic and Social Research Council and the Medical ... applications to be funded under the programme. , ...
... Oct. 18 ReBuilder,Medical Technologies, Inc. (Pink ... by world-renowned medical device inventor David B.,Phillips, ... service organization and facilitation. (Logo: ... when many companies are outsourcing customer service ...
... Cost of Prescription Drugs, WASHINGTON, Oct. 18 ... following statement in response to,today,s House Judiciary Committee ... independent pharmacists sweeping antitrust,exemptions:, "This bill couldn,t ... and,consumers alike. As most everyone is searching for ...
... UK awarding body associated with hairdressing and beauty therapy ... a major UK Centre for Burns Research based at ... of its kind by The Vocational Training Charitable Trust ... pioneering research programme soon to start in South Wales. ...
... Children Under 5 in Madagascar to Sleep Under Bed ... More and,Sumitomo Chemical have teamed up to contribute to ... Madagascar between October 22-29. Led by the Malagasy ... six months to five years old receives a bed ...
... The Bayer Foundation,announced today it has awarded ... of Chemical & Biomolecular Engineering (UH CHBE) to,establish ... which is competitive with other prestigious fellowships,from the ... over a,three-year period to a graduate student pursuing ...
Cached Medicine News:Health News:Research for a better old age 2Health News:Research for a better old age 3Health News:ReBuilder Medical Technologies, Inc. Hires Nurses Exclusively to Provide Customer Support 2Health News:ReBuilder Medical Technologies, Inc. Hires Nurses Exclusively to Provide Customer Support 3Health News:£1 million donation for burns research in Wales 2Health News:Malaria No More and Sumitomo Chemical Help Protect 1.4 Million Kids from Malaria 2Health News:Malaria No More and Sumitomo Chemical Help Protect 1.4 Million Kids from Malaria 3Health News:Bayer Foundation Grant Creates Graduate Engineering Fellowship at University of Houston 2Health News:Bayer Foundation Grant Creates Graduate Engineering Fellowship at University of Houston 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: